Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increasing availability of funds for research
4.1.2 Growth in adoption of high throughput screening methods
4.1.3 Advancements in drug discovery activity
4.1.4 Rising incidence of chronic diseases
4.2 Restraints
4.2.1 High investments and maintenance costs
4.2.2 Lack of skilled people to handle technology
4.3 Opportunities
4.3.1 Asian countries
4.3.2 Augmenting adoption of label-free-cell-based-array
4.4 Challenges
4.4.1 Maintenance of cell line
4.4.2 Lack of awareness about the utility of instruments for the end-user.
Chapter 5 Europe Cell-Based Assay Market – By Type of product
5.1 Assay Ready Kites
5.2 Cell Lines
5.2.1 Stem cell lines
5.2.2 Primary cell lines
5.2.3 Immortalized cell lines
5.2.4 Others
5.3 Ligands & Inhibitors
5.4 Cell culture kits, reagents & consumers
5.5 Others
Chapter 6 Europe Cell-Based Assay Market – By Technology
6.1 Flow cytometry
6.2 High content screening
6.3 Automated handling
6.4 High Throughput Screening
6.5 label-free detection
6.6 Others
Chapter 7 Europe Cell-Based Assay Market - By Application
7.1 ADME research
7.2 Drug discovery
7.3 Others
Chapter 8 Europe Cell-Based Assay Market - By End-User
8.1 Biotechnology
8.2 Pharmaceuticals
8.3 Academia
8.4 CRO
8.5 Others
Chapter 9 Europe Cell-Based Assay Market - By Country
9.1 Introduction
9.2 Europe
9.2.1 U.K.
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6. Rest Of Europe
Chapter 10 Europe Cell-Based Assay System Market - Company Profiles
10.1 Ametek, Inc
10.2 Promega Corporation
10.3 GE Healthcare
10.4 Bio-Rad Laboratories
10.5 Roche Diagnostics
10.6 Pall Corporation
10.7 Danaher Corporation
10.8 Cisbio Bioassays
10.9Perkinelmer, Inc
10.10 Danaher Corporation
10.11 Thermo Fisher Scientific Inc.
10.12 Cell Signaling Technology
10.13 Discoverx Corporation
Chapter 11 Europe Cell-Based Assay Market - Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 12 Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
